Results for "imatinib" | Prospecte.ro

IMATINIB ZENTIVA 400mg film-coated tablets

Chemical substance: imatinib

ATC code: L01EA01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | BCR-ABL tyrosine kinase inhibitors

Prescription

P-RF
IMAVEC 100mg film-coated tablets HELM

Chemical substance: imatinib

ATC code: L01EA01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | BCR-ABL tyrosine kinase inhibitors

Prescription

P-RF
IMAVEC 400mg film-coated tablets HELM

Chemical substance: imatinib

ATC code: L01EA01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | BCR-ABL tyrosine kinase inhibitors

Prescription

P-RF
LATIB 100mg capsules EGIS

Chemical substance: imatinib

ATC code: L01EA01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | BCR-ABL tyrosine kinase inhibitors

Prescription

P-RF
LATIB 400mg capsules EGIS

Chemical substance: imatinib

ATC code: L01EA01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | BCR-ABL tyrosine kinase inhibitors

Prescription

P-RF
LEUMAT 100mg film-coated tablets LICONSA

Chemical substance: imatinib

ATC code: L01EA01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | BCR-ABL tyrosine kinase inhibitors

Prescription

P-RF
LEUMAT 300mg film-coated tablets LICONSA

Chemical substance: imatinib

ATC code: L01EA01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | BCR-ABL tyrosine kinase inhibitors

Prescription

P-RF
LEUMAT 400mg film-coated tablets LICONSA

Chemical substance: imatinib

ATC code: L01EA01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | BCR-ABL tyrosine kinase inhibitors

Prescription

P-RF
MEAXIN 100mg dispersible tablets KRKA

Chemical substance: imatinib

ATC code: L01EA01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | BCR-ABL tyrosine kinase inhibitors

Prescription

P-RF
MEAXIN 100mg film-coated tablets KRKA

Chemical substance: imatinib

ATC code: L01EA01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | BCR-ABL tyrosine kinase inhibitors

Prescription

P-RF
MEAXIN 400mg dispersible tablets KRKA

Chemical substance: imatinib

ATC code: L01EA01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | BCR-ABL tyrosine kinase inhibitors

Prescription

P-RF
MEAXIN 400mg film-coated tablets KRKA

Chemical substance: imatinib

ATC code: L01EA01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | BCR-ABL tyrosine kinase inhibitors

Prescription

P-RF
NEOXELL 100mg film-coated tablets NEOLA PHARMA

Chemical substance: imatinib

ATC code: L01EA01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | BCR-ABL tyrosine kinase inhibitors

Prescription

P-RF
NEOXELL 400mg film-coated tablets NEOLA PHARMA

Chemical substance: imatinib

ATC code: L01EA01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | BCR-ABL tyrosine kinase inhibitors

Prescription

P-RF
NIBIX 100mg capsules TERAPIA

Chemical substance: imatinib

ATC code: L01EA01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | BCR-ABL tyrosine kinase inhibitors

Prescription

P-RF
NIBIX 400mg capsules TERAPIA

Chemical substance: imatinib

ATC code: L01EA01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | BCR-ABL tyrosine kinase inhibitors

Prescription

P-RF
VENZAN 100mg film-coated tablets BIOFARM

Chemical substance: imatinib

ATC code: L01EA01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | BCR-ABL tyrosine kinase inhibitors

Prescription

P-RF
VENZAN 400mg film-coated tablets BIOFARM

Chemical substance: imatinib

ATC code: L01EA01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | BCR-ABL tyrosine kinase inhibitors

Prescription

P-RF

Results for the substance imatinib

imatinib

Indicated for: chronic myeloid leukemia; gastrointestinal stromal tumors

L01EA01 Antineoplastic and immunomodulating agents | Protein kinase inhibitors | BCR-ABL tyrosine kinase inhibitors